[
  {
    "date": "2023-12-30",
    "symbol": "CLGN",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 26674000,
    "restrictedinvestmentscurrent": 241000,
    "prepaidexpenseandotherassetscurrent": 393000,
    "inventorynet": 714000,
    "assetscurrent": 28022000,
    "restrictedinvestmentsnoncurrent": 57000,
    "operatingleaserightofuseasset": 3070000,
    "propertyplantandequipmentnet": 2789000,
    "intangibleassetsnetexcludinggoodwill": 188000,
    "assetsnoncurrent": 6104000,
    "assets": 34126000,
    "accountspayabletradecurrent": 980000,
    "operatingleaseliabilitycurrent": 624000,
    "accruedliabilitiesandotherliabilities": 1647000,
    "liabilitiescurrent": 3251000,
    "operatingleaseliabilitynoncurrent": 2535000,
    "liabilitiesnoncurrent": 2535000,
    "liabilities": 5786000,
    "commonstockvalue": 4982000,
    "additionalpaidincapitalcommonstock": 121068000,
    "accumulatedothercomprehensiveincomelossnetoftax": -969000,
    "retainedearningsaccumulateddeficit": -96741000,
    "stockholdersequity": 28340000,
    "liabilitiesandstockholdersequity": 34126000,
    "commonstockparorstatedvaluepershare": 1.5,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 11452672,
    "commonstocksharesoutstanding": 11452672,
    "revenues": 10959000,
    "costofrevenue": 1991000,
    "grossprofit": 8968000,
    "researchanddevelopmentexpense": 10484000,
    "generalandadministrativeexpense": 5996000,
    "operatingincomeloss": -7512000,
    "nonoperatingincomeexpense": 493000,
    "netincomeloss": -7019000,
    "earningspersharebasic": -0.62,
    "earningspersharediluted": -0.62,
    "weightedaveragenumberofsharesoutstandingbasic": 11389168,
    "weightedaveragenumberofdilutedsharesoutstanding": 11389168,
    "stockissuedduringperiodvalueexerciseofwarrants": 76000,
    "stockissueduringperiodsharesexerciseofwarrants": 186000,
    "stockissuedduringperiodvaluestockoptionsexercised": 33000,
    "stockissuedduringperiodsharesstockoptionsexercised": 80191,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 1970000,
    "gainlossonsaleofpropertyplantequipment": -18000,
    "depreciationdepletionandamortization": 1102000,
    "accruedinterest": 28000,
    "sharebasedcompensation": 1937000,
    "effectofexchangeratechangesoncashandcashequivalent": -379000,
    "increasedecreaseinaccountsreceivable": -9000,
    "increasedecreaseininventories": -749000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -150000,
    "increasedecreaseinotheroperatingassets": -527000,
    "increasedecreaseinaccountspayabletrade": -153000,
    "increasedecreaseinoperatingleaseliability": -638000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 204000,
    "netcashprovidedbyusedinoperatingactivities": -2763000,
    "paymentstoacquirepropertyplantandequipment": 954000,
    "paymentstoacquirerestrictedcertificatesofdeposit": 270000,
    "proceedsfromsaleofpropertyplantandequipment": 68000,
    "netcashprovidedbyusedininvestingactivities": -1156000,
    "proceedsfromexerciseofoptionsandwarrantsintoshares": 1108000,
    "netcashprovidedbyusedinfinancingactivities": 1108000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -379000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -3190000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 26674000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 886000,
    "capitalizationofsharebasedcompensationtoinventory": 33000,
    "incometaxespaidnet": 8000,
    "functionalcurrencypolicytextblock": "c. Financial statements in U.S. dollars:",
    "scheduleofestimatedusefullivespropertyandequipmenttabletextblock": "The depreciation period is as follows:",
    "scheduleofsupplementalbalancesheetinformationrelatedtoleases": "Supplemental balance sheet informationrelated to leases was as follows:",
    "scheduleofsharesissuedgrantedoptionstabletextblock": "In the years ended December 31, 2023, 2022 and2021, the Company granted options as follows (amounts presented reflect the number of shares underlying options):",
    "scheduleofrevenuebymajorcustomerstabletextblock": "Set forth below is a breakdown of theCompany’s revenue by major customers (major customer –revenues from these customers constitute at least 10% of total revenuesin a certain year):",
    "propertyplantandequipmentusefullife": "P5Y",
    "inventoryworkinprocess": 173000,
    "inventoryfinishedgoods": 541000,
    "propertyplantandequipmentgross": 1979000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6046000,
    "operatingleasepayments": 809000,
    "operatingleaseliability": 3159000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y1M20D",
    "operatingleaseweightedaveragediscountratepercent": 0.0746,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 824000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 768000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 664000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 636000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 627000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 303000,
    "lesseeoperatingleaseliabilitypaymentsdue": 3822000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 663000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 158000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 5.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvaluesassumptionsexerciseprice": 5.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7027,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 271000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 4380000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1745880,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y9M21D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 83156,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 9.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 121272,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 8.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 5.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y10M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 1165000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1151015,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.49,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P4Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 1062000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P1Y4M17D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 1329,
    "allocatedsharebasedcompensationexpense": 714000,
    "deferredtaxassetsoperatinglosscarryforwards": 15492000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1993000,
    "deferredtaxassetoperatingleaseliabilities": 726000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1035000,
    "deferredtaxassetsgross": 19246000,
    "deferredtaxassetsvaluationallowance": 18540000,
    "deferredtaxliabilitiesleasingarrangements": 706000,
    "valuationallowancedeferredtaxassetchangeinamount": -3926000,
    "accruedemployeebenefitscurrent": 1052000,
    "accruedvacationcurrent": 490000,
    "accruedroyaltiescurrent": 105000,
    "revenuefromcontractwithcustomerincludingassessedtax": 10000000,
    "exchangeratedifferences": 285000,
    "bankandotherfees": 10000,
    "investmentincomeinterest": 788000,
    "cashequivalentsatcarryingvalue": 26674000,
    "assetacquisitioncontingentconsiderationliability": 14000000,
    "terminationloans": 14000000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2007546,
    "inventorywritedown": 866000,
    "depreciation": 1045000,
    "operatingleasecost": 775000,
    "variableleasepayment": 52000,
    "percentageofincomefromproductandservices": 0.03,
    "royaltyexpense": 329000,
    "royaltyguaranteescommitmentsamount": 6987000,
    "warrantsexercisedescription": "In 2021, one of the U.S investors exercised 450,000 warrants into 450,000 ordinary shares in return of $1,800.   In 2022, three U.S investors exercised 425,000 warrants into 425,000 ordinary shares in return of $1,700.   In 2023, Mr. Sagy exercised 186,000 warrants into 186,000 ordinary shares in return of $744.",
    "classofwarrantorrightoutstanding": 186000,
    "sharesreturn": 744000,
    "descriptionofinvestors": "On the same date, one of the Company’s investors transferred the Company an amount of $1,000 by way of an equity investment, and the Company issued to the investor 250,000 ADSs representing 250,000 ordinary shares and a warrant to purchase up to 250,000 ADSs representing 250,000 ordinary shares.",
    "equitymethodinvestments": 1000,
    "investorshares": 250000,
    "fairvalueoptionsgranted": 747000,
    "employeebenefitsandsharebasedcompensation": 1342000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaverageexpecteddividend": 579000,
    "otherexpenses": 523,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.23,
    "incometaxexpensebenefit": 7365000,
    "entityregistrantname": "CollPlant Biotechnologies Ltd.",
    "tradingsymbol": "CLGN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 11452672,
    "amendmentflag": "false",
    "entitycentralindexkey": 1631487,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38370",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "4 Oppenheimer",
    "entityaddressaddressline2": "Weizmann Science Park",
    "entityaddresscityortown": "Rehovot",
    "entityaddresspostalzipcode": 7670104,
    "entityaddresscountry": "IL",
    "contactpersonnelname": "Yehiel Tal",
    "cityareacode": 972,
    "localphonenumber": "73 232 5600",
    "contactpersonnelemailaddress": "Yehiel@CollPlant.com",
    "security12btitle": "Ordinary shares, par value NIS 1.50 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1281,
    "auditorname": "Kost Forer Gabbay & Kasierer",
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2022-12-31",
    "symbol": "CLGN",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 29653000,
    "restricteddepositcurrent": 23000,
    "accountsreceivablenetcurrent": 9000,
    "prepaidexpenseandotherassetscurrent": 543000,
    "inventorynet": 1430000,
    "assetscurrent": 31658000,
    "restricteddepositnoncurrent": 188000,
    "operatingleaserightofuseasset": 2711000,
    "propertyplantandequipmentnet": 2966000,
    "intangibleassetsnetexcludinggoodwill": 245000,
    "assetsnoncurrent": 6110000,
    "assets": 37768000,
    "accountspayabletradecurrent": 1133000,
    "operatingleaseliabilitycurrent": 2911000,
    "accruedliabilitiesandotherliabilities": 1443000,
    "liabilitiescurrent": 3105000,
    "operatingleaseliabilitynoncurrent": 2382000,
    "liabilitiesnoncurrent": 2382000,
    "liabilities": 5487000,
    "commonstockvalue": 4873000,
    "additionalpaidincapitalandwarrants": 118099000,
    "currencytranslationdifferences": -969000,
    "retainedearningsaccumulateddeficit": -89722000,
    "stockholdersequity": -89722000,
    "liabilitiesandstockholdersequity": 37768000,
    "commonstockparorstatedvaluepershare": 1.5,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 11186481,
    "commonstocksharesoutstanding": 10772024,
    "revenues": 158000,
    "costofrevenue": 400000,
    "grossprofit": -101000,
    "researchanddevelopmentexpense": 10255000,
    "generalandadministrativeexpense": 6741000,
    "operatingincomeloss": -17097000,
    "nonoperatingincomeexpense": 172000,
    "netincomeloss": -16925000,
    "earningspersharebasic": -1.53,
    "earningspersharediluted": -1.53,
    "weightedaveragenumberofsharesoutstandingbasic": 11033310,
    "weightedaveragenumberofdilutedsharesoutstanding": 11033310,
    "sharesoutstanding": 11186481,
    "stockissuedduringperiodvalueother": 1700000,
    "stockissuedduringperiodsharesother": 425000,
    "stockissuedduringperiodvaluestockoptionsexercised": 174000,
    "stockissuedduringperiodsharesstockoptionsexercised": 39457,
    "stockissuedduringperiodvaluesharebasedcompensation": 2211000,
    "profitloss": -16925000,
    "depreciation": 1076000,
    "gainlossonsaleofinvestments": 87000,
    "sharebasedcompensationtoemployeesandconsultants": 2174000,
    "effectofexchangeratechangesoncashandcashequivalent": -608000,
    "increasedecreaseinaccountsreceivable": -261000,
    "increasedecreaseininventories": 312000,
    "increasedecreaseinotherreceivables": 119000,
    "increasedecreaseinothernoncurrentasset": -461000,
    "increasedecreaseinaccountspayabletrade": 99000,
    "increasedecreaseinoperatingleaseliability": -916000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 14000,
    "increasedecreaseindeferredrevenue": -32000,
    "netcashprovidedbyusedinoperatingactivities": -13698000,
    "paymentstoacquireintangibleassets": 42000,
    "paymentstoacquirepropertyplantandequipment": 1274000,
    "proceedfromothershorttermdeb": 50238000,
    "paymentstoacquireinvestments": 20000000,
    "netcashprovidedbyusedininvestingactivities": 28922000,
    "proceedsfromwarrantexercises": 1874000,
    "netcashprovidedbyusedinfinancingactivities": 1874000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -608000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 16490000,
    "cashandcashequivalentsatcarryingvalueincludingdiscontinuedoperations": 29864000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 219000,
    "capitalizationofsharebasedcompensationtoinventory": 37000,
    "cashpaidduringtheyearfortaxes": 31000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsdisposalgroupincludingdiscontinuedoperations": 29653000,
    "restricteddepositsshortterm": 23000,
    "restricteddepositincludinglongterm": 188000,
    "restrictedcashandcashequivalents": 29864000,
    "licensedevelopmentandcommercializationagreementstextblock": "NOTE 7 – DEVELOPMENT , EXCLUSIVITY ANDOPTION PRODUCTS AGREEMENTS  ",
    "supplementaryfinancialstatementinformationtextblock": "NOTE 10 - SUPPLEMENTARY FINANCIAL STATEMENTINFORMATION: ",
    "functionalcurrencypolicytextblock": "  c. Functional currency    ",
    "descriptionofaccountingpolicyfornewlyissuedandrecentlyadoptedaccountingpronouncementsexplanatorypolicytextblock": "  u.  Newly issued and recently adopted accountingpronouncements:   ",
    "scheduleofestimatedusefullivespropertyandequipmenttabletextblock": "            Years                   Laboratory equipment     5      Greenhouse equipment*     4 - 10      Computer equipment     3      Office furniture     17      Leasehold improvements     **      Electronic equipment     7      Vehicles     7   ",
    "scheduleofsharesissuedgrantedoptionstabletextblock": "            Year ended December 31, 2022                  Award amount      Exercise price range      Vesting period     Expiration      Employees      529,000      $5.33-9.22      4 years     10 years      Directors      217,000      $9.22      4 years     10 years   ",
    "scheduleoffairvalueoptionsgrantedtabletextblock": "            Year ended December 31,             2022      2021      2020       Value of one ordinary share     $ 5.03-9.22      $11.9-20.37      $7.86-10.5       Dividend yield      0%      0%      0%      Expected volatility      67.95-72.27%      65.36-66.49%      66.12-66.41%      Risk-free interest rate      0.39-3.03%      0.64-1.37%      0.45-0.52%      Expected term      6.11 years       6.11 years       6.11 years    ",
    "scheduleofdisaggregatedrevenuestextblock": "            Year ended December 31             2022      2021      2020       Revenues from licensing agreement (see Note 2(q))     $-      $14,000      $3,600       Revenues from the sales of goods      299       1,595       2,108       Revenues from the rendering of services      -       46       429       Total revenues     $299      $15,641      $6,137    ",
    "scheduleofrevenuesbygeographicalareatabletextblock": "            Year ended December 31             2022      2021      2020       United states and Canada     $174      $15,013      $5,768       Europe and Israel      125       628       369       Total revenues     $299      $15,641      $6,137    ",
    "scheduleofrevenuebymajorcustomerstabletextblock": "            2022      2021      2020       Customer  A     $9      $14,770      $822                                      Customer B     $101      $*)      $*)                                      Customer C     $158      $*)      $*)       Customer D     $-      $169      $4,929    ",
    "propertyplantandequipmentusefullife": 7,
    "propertyplantandequipmentgross": 8007000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5041000,
    "inventoryworkinprocess": 881000,
    "inventoryfinishedgoods": 549000,
    "inventorygross": 1430000,
    "operatingleasepayments": 770000,
    "operatingleaseliability": 2911000,
    "operatingleaseweightedaverageremainingleaseterm1": 5.7,
    "operatingleaseweightedaveragediscountratepercent": 0.0713,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 709000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 604000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 550000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 524000,
    "lesseeoperatingleaseliabilitypaymentsdueafterrollingyearfive": 1143000,
    "lesseeoperatingleaseliabilitypaymentsdue": 3530000,
    "lesseeoperatingleaseliabilityimputedinterest": 619000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 746000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 9.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 1.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvaluesassumptionsexerciseprice": 9.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.7227,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 3.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 221000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2802000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 2.54,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.54,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 3438,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 10.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 55050,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 11.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 15416,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 16.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 1.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 202000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 9766,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.47,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 2.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 65000,
    "optionsoutstandingexerciseprices": 5.33,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 1884165,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 9.92,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 924139,
    "effectofsharebasedcompensation": 2174000,
    "deferredtaxassetsoperatinglosscarryforwards": 20105000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1736000,
    "deferredtaxassetstaxdeferredexpenseother": 230000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 670000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 349000,
    "deferredtaxassetsgross": 23090000,
    "deferredtaxassetsnet": 22466000,
    "deferredtaxliabilitiesleasingarrangements": 624000,
    "deferredtaxassetsvaluationallowance": 22466000,
    "valuationallowancedeferredtaxassetchangeinamount": 6650000,
    "pensionandotherpostretirementdefinedbenefitplansliabilitiesnoncurrent": 1443000,
    "revenuesfromsalesofgoods": 299000,
    "contractwithcustomerliabilityrevenuesrecognized": 32000,
    "exchangeratedifferences": -115000,
    "bankandotherfees": 10000,
    "othernonoperatingexpense": 24000,
    "shorttermborrowings": 321000,
    "investmentincomenet": -172000,
    "assetacquisitioncontingentconsiderationliability": 14000000,
    "terminationloans": 14000000,
    "otherdepreciationandamortization": 1036000,
    "disposedoffixedassets": 7000,
    "inventorywritedown": 296000,
    "lessoroperatingleasetermofcontract": "three years",
    "paymentstoacquirerestrictedcertificatesofdeposit": 188000,
    "operatingleasesincomestatementinitialdirectcosts": 645000,
    "variableleasepayment": 24000,
    "incomepercentage": 0.03,
    "royaltyexpense": 9000,
    "grantsreceivable": 10100000,
    "paymentsforroyalties": 2800000,
    "royaltyguaranteescommitmentsamount": 7314000,
    "proceedsfromfeesreceived": 53000000,
    "proceedsfromotherdeposits": 53000000,
    "nonrefundablepayment": 4000000,
    "othernotespayable": 43000000,
    "debtinstrumentterm": 10,
    "classofwarrantorrightoutstanding": 425000,
    "sharesreturn": 1700000,
    "fairvalueoptionsgranted": 3970000,
    "employeebenefitsandsharebasedcompensation": 2637000,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.23,
    "operatinglosscarryforwards": 66339000,
    "concentrationriskpercentage2": 0.1,
    "lessthanpercentage": 0.1,
    "entityregistrantname": "CollPlant BiotechnologiesLtd.",
    "tradingsymbol": "CLGN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 11186481,
    "amendmentflag": "false",
    "entitycentralindexkey": 1631487,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38370",
    "entityincorporationstatecountrycode": "Israel",
    "entityaddressaddressline1": "4 Oppenheimer",
    "entityaddressaddressline2": "WeizmannScience Park",
    "entityaddresscityortown": "Rehovot",
    "entityaddresspostalzipcode": 7670104,
    "entityaddresscountry": "Israel",
    "contactpersonnelname": "Yehiel Tal",
    "cityareacode": 972,
    "localphonenumber": "73 232 5600",
    "security12btitle": "Ordinary shares, par value NIS 1.50 per share",
    "securityexchangename": "Nasdaq Global Market",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorfirmid": 1281,
    "auditorname": "KOST FORER GABBAY & KASIERER",
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2021-12-31",
    "symbol": "CLGN",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 13148000,
    "shorttermcashdeposits": 30151000,
    "restricteddepositcurrent": 13000,
    "accountsreceivablenetcurrent": 270000,
    "prepaidexpenseandotherassetscurrent": 424000,
    "inventorynet": 1081000,
    "assetscurrent": 45087000,
    "restricteddepositnoncurrent": 213000,
    "operatingleaserightofuseasset": 2953000,
    "propertyplantandequipmentnet": 2728000,
    "intangibleassetsnetexcludinggoodwill": 243000,
    "assetsnoncurrent": 6137000,
    "assets": 51224000,
    "accountspayabletradecurrent": 1034000,
    "operatingleaseliabilitycurrent": 3608000,
    "deferredrevenues": 32000,
    "accruedliabilitiesandotherliabilities": 1429000,
    "liabilitiescurrent": 3014000,
    "operatingleaseliabilitynoncurrent": 3089000,
    "liabilitiesnoncurrent": 3089000,
    "liabilities": 6103000,
    "commonstockvalue": 4664000,
    "additionalpaidincapitalandwarrants": 114223000,
    "currencytranslationdifferences": -969000,
    "retainedearningsaccumulateddeficit": -72797000,
    "stockholdersequity": -72797000,
    "liabilitiesandstockholdersequity": 51224000,
    "commonstockparorstatedvaluepershare": 1.5,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 10772024,
    "commonstocksharesoutstanding": 10772024,
    "revenues": 14770000,
    "costofrevenue": 2005000,
    "grossprofit": 13636000,
    "researchanddevelopmentexpense": 7631000,
    "generalandadministrativeexpense": 5940000,
    "operatingincomeloss": 65000,
    "nonoperatingincomeexpense": 172000,
    "netincomeloss": 237000,
    "earningspersharebasic": 0.02,
    "earningspersharediluted": 0.02,
    "weightedaveragenumberofsharesoutstandingbasic": 9968972,
    "weightedaveragenumberofdilutedsharesoutstanding": 11966788,
    "sharesoutstanding": 10722024,
    "increasedecreaseinnumberofordinarysharesissuedvalue": 32793000,
    "stockissuedduringperiodsharesnewissues": 2250000,
    "stockissuedduringperiodvalueother": 5718000,
    "stockissuedduringperiodsharesother": 1442149,
    "stockissuedduringperiodvaluestockoptionsexercised": 299000,
    "stockissuedduringperiodsharesstockoptionsexercised": 66037,
    "adjustmentstoadditionalpaidincapitaltaxeffectfromsharebasedcompensation": 1597000,
    "issuanceofordinarysharesandwarrants": 3205000,
    "stockissuedduringperiodvaluenewissues": 51000,
    "profitloss": -237000,
    "depreciation": 773000,
    "gainlossonsaleofinvestments": 151000,
    "sharebasedcompensationtoemployeesandconsultants": 1597000,
    "effectofexchangeratechangesoncashandcashequivalent": 143000,
    "financialexpensesrelatedtofinancialinstruments": -28000,
    "increasedecreaseinaccountsreceivable": -560000,
    "increasedecreaseininventories": -181000,
    "increasedecreaseinotherreceivables": 185000,
    "increasedecreaseinothernoncurrentasset": -400000,
    "increasedecreaseinaccountspayabletrade": 236000,
    "increasedecreaseinoperatingleaseliability": -337000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -464000,
    "increasedecreaseindeferredrevenue": -175000,
    "netcashprovidedbyusedinoperatingactivities": 2501000,
    "paymentstoacquireintangibleassets": 161000,
    "paymentstoacquirepropertyplantandequipment": 1428000,
    "paymentstoacquireinvestments": 30000000,
    "proceedsfromsaleofpropertyplantandequipment": 33000,
    "netcashprovidedbyusedininvestingactivities": -31556000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 32743000,
    "proceedsfromwarrantexercises": 6017000,
    "netcashprovidedbyusedinfinancingactivities": 38760000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 9705000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 13374000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 143000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 557000,
    "proceedsfromissuanceofcommonstock": 50000,
    "restricteddepositincludinglongterm": 226000,
    "restrictedcashandcashequivalents": 13374000,
    "licensedevelopmentandcommercializationagreementstextblock": "NOTE 8 – DEVELOPMENT , EXCLUSIVITY ANDOPTION PRODUCTS AGREEMENTS  ",
    "supplementaryfinancialstatementinformationtextblock": "NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENTINFORMATION: ",
    "functionalcurrencypolicytextblock": "  c. Functional currency       ",
    "descriptionofaccountingpolicyfornewlyissuedandrecentlyadoptedaccountingpronouncementsexplanatorypolicytextblock": "  t. Newly issued and recently adopted accounting pronouncements:      ",
    "scheduleofestimatedusefullivespropertyandequipmenttabletextblock": "            Years                     Laboratory equipment      4 - 5       Greenhouse equipment*      4 - 10       Computer equipment      3       Office furniture      7 - 17        Leasehold improvements      **       Vehicles      4-7    ",
    "scheduleofassumptionusedformodelstabletextblock": "            Ami Sagy*      US     investors - 2019     agreement             2020      2020       Probability      3%      3%                             Expected volatility      71.19%      70.78%      Risk free interest rate      0.12%      0.12%      Expected term (years)      1.68       1.68    ",
    "scheduleofsupplementalcashflowinformationrelatedtoleases": "            Year ended December 31,             2021      2020       Operating cash flows from operating leases     $702      $657    ",
    "scheduleofmaturitiesofleaseliabilities": "                Operating    leases           Year ending December 31,                          2022         $    757           2023              699           2024              583           2025              593           2026 and thereafter              1,887           Total lease payments              4,519           Less - imputed interests              (911    )      Total              3,608       ",
    "scheduleofsharesissuedgrantedoptionstabletextblock": "            Year ended December 31, 2021             Award     amount      Exercise     price range      Vesting     period      Expiration       Employees      96,500      $12.78-20.7       4 years       10 years       Directors      23,000      $15.2       4 years       10 years    ",
    "scheduleoffairvalueoptionsgrantedtabletextblock": "            2019       Value of one ordinary share     $5.93       Dividend yield      0%      Expected volatility      62%      Risk-free interest rate      2%      Expected term      4 years    ",
    "scheduleofdisaggregatedrevenuestextblock": "            Year ended December 31             2021     2020     2019       Revenues from licensing agreement (see Note 2(p))     $14,000     $3,600     $-       Revenues from the sales of goods      1,595      2,108      1,949       Revenues from the rendering of services      46      429      369       Total revenues     $15,641     $6,137     $2,318    ",
    "scheduleofrevenuesbygeographicalareatabletextblock": "            Year ended December 31             2021     2020     2019       United states and Canada     $15,013     $5,768     $2,078       Europe      628      369      240       Total revenues     $15,641     $6,137     $2,318    ",
    "scheduleofrevenuebymajorcustomerstabletextblock": "            2021     2020     2019       Customer  A     $169     $4,929     $1,374                                    Customer B     $14,770     $822     $242                                    Customer C     $-     $-     $419    ",
    "propertyplantandequipmentusefullife": 7,
    "profitfromchangesinfairvalueofdebentures": 28000,
    "propertyplantandequipmentgross": 6741000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 4013000,
    "inventoryworkinprocess": 693000,
    "inventoryfinishedgoods": 388000,
    "inventorygross": 1081000,
    "operatingleasepayments": 702000,
    "operatingleaseliability": 3608000,
    "operatingleaseweightedaverageremainingleaseterm1": 6.7,
    "operatingleaseweightedaveragediscountratepercent": 0.0733,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 757000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 699000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 583000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 593000,
    "lesseeoperatingleaseliabilitypaymentsdueafterrollingyearfive": 1887000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4519000,
    "lesseeoperatingleaseliabilityimputedinterest": 911000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 119500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 15.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 1.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvaluesassumptionsexerciseprice": 20.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6648999999999999,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.013700000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1220694,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.02,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.69,
    "stockissuedduringperiodssharesstockoptionsexercised": 66037,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 2666,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 64.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 31546,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 7891,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.2,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 15416,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 1236110,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 3.12,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 744970,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 3.08,
    "effectofsharebasedcompensation": 1620000,
    "deferredtaxassetsoperatinglosscarryforwards": 14391000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1280000,
    "valuationoffinancialinstruments": 6000,
    "deferredtaxassetsnet": 15665000,
    "deferredtaxassetsvaluationallowance": 15665000,
    "valuationallowancedeferredtaxassetchangeinamount": 159000,
    "pensionandotherpostretirementdefinedbenefitplansliabilitiesnoncurrent": 1429000,
    "revenuesfromlicensingagreement": 14000000,
    "revenuesfromsalesofgoods": 1595000,
    "revenuesfromrenderingofservices": 46000,
    "contractwithcustomerliabilityincreasedecreaseforcontractacquiredinbusinesscombination": -32000,
    "contractwithcustomerliabilityrevenuesrecognized": 207000,
    "balanceatendofyear": 32000,
    "contractwithcustomerliabilitycurrent": 32000,
    "effectofexchangerateoncash": -38000,
    "longtermdebt": 30000,
    "remeasurementoffinancialinstruments": 28000,
    "othernonoperatingexpense": 7000,
    "shorttermborrowings": 219000,
    "investmentincomenet": -172000,
    "assetacquisitioncontingentconsiderationliability": 14000,
    "terminationloans": 14000,
    "transactionprice": 5000000,
    "reimbursementcost": 1000000,
    "effectiveincometaxratecontinuingoperations": 0.5,
    "warrantsexercisable": 1590346,
    "disposedoffixedassets": 33000,
    "inventorywritedown": 367000,
    "othercostandexpenseoperating": 6000,
    "paymentstoacquirerestrictedcertificatesofdeposit": 213000,
    "lessoroperatingleasetermofcontract": "three years",
    "operatingleasesincomestatementinitialdirectcosts": 646000,
    "variableleasepayment": 12000,
    "artistadvancesandroyaltyguaranteescommitments": "Under the Innovation Law the rate of royalties varies between3% to 5% computed based on the revenues from the products that their development was also funded by grants from the IIA. In addition,revenues from certain milestone under the LB license, development and commercialization agreement were subject to royalties rate of 24.8%.Such commitment is up to the amount of grants received (dollar linked), plus interest at annual rate based on LIBOR.",
    "royaltyexpense": 468000,
    "royaltyguaranteescommitmentsamount": 7328000,
    "upfrontcashpayment": 5000000,
    "broadcasterslicenseagreementcommitmentsdescription": "In addition, the License Agreement provides for a one-time non-refundable option payments of $3,000 per Option Product($9,000 in the aggregate), and up to $30,000 of milestone payments payable as follows: (i) $5,000 upon completion of the U.S. facilitydesign, (ii) $5,000 upon completion of production of a specified amount of BioInk, and (iii) $5,000 for FDA marketing approval for eachCovered Product (up to $20,000 in the aggregate).",
    "classofwarrantorrightoutstanding": 450000,
    "sharesreturn": 1800000,
    "fairvalueoptionsgranted": 1094000,
    "employeebenefitsandsharebasedcompensation": 1339000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 1023000,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.23,
    "operatinglosscarryforwards": 54807000,
    "concentrationriskpercentage2": 0.1,
    "entityregistrantname": "CollPlant BiotechnologiesLtd.",
    "tradingsymbol": "CLGN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 10772024,
    "amendmentflag": "false",
    "entitycentralindexkey": 1631487,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38370",
    "entityincorporationstatecountrycode": "Israel",
    "entityaddressaddressline1": "4 Oppenheimer",
    "entityaddressaddressline2": "WeizmannScience Park",
    "entityaddresscityortown": "Rehovot",
    "entityaddresspostalzipcode": 7670104,
    "entityaddresscountry": "Israel",
    "contactpersonnelname": "Yehiel Tal",
    "cityareacode": 972,
    "localphonenumber": "73 232 5600",
    "security12btitle": "Ordinary shares, par value NIS 1.50 per share",
    "securityexchangename": "Nasdaq Global Market",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "U.S. GAAP",
    "auditorname": "Kost Forer Gabay & Kasierer",
    "auditorfirmid": 1281,
    "auditorlocation": "Tel-Aviv, Israel"
  },
  {
    "date": "2020-12-31",
    "symbol": "CLGN",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 3333000,
    "restricteddepositcurrent": 12000,
    "accountsreceivablenetcurrent": 830000,
    "prepaidexpenseandotherassetscurrent": 239000,
    "inventorynet": 1262000,
    "assetscurrent": 5676000,
    "restricteddepositnoncurrent": 181000,
    "operatingleaserightofuseasset": 2796000,
    "propertyplantandequipmentnet": 2106000,
    "intangibleassetsnetexcludinggoodwill": 82000,
    "assetsnoncurrent": 5165000,
    "assets": 10841000,
    "accountspayabletradecurrent": 798000,
    "operatingleaseliabilitycurrent": 3388000,
    "deferredrevenues": 207000,
    "accruedliabilitiesandotherliabilities": 1943000,
    "liabilitiescurrent": 3388000,
    "derivativeliabilitiesnoncurrent": 28000,
    "operatingleaseliabilitynoncurrent": 2948000,
    "liabilitiesnoncurrent": 2976000,
    "liabilities": 6364000,
    "commonstockvalue": 2933000,
    "additionalpaidincapitalandwarrants": 75547000,
    "currencytranslationdifferences": -969000,
    "retainedearningsaccumulateddeficit": -73034000,
    "stockholdersequity": -73034000,
    "liabilitiesandstockholdersequity": 10841000,
    "commonstockparorstatedvaluepershare": 1.5,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesoutstanding": 6963838,
    "commonstocksharesissued": 6963838,
    "revenues": 6137000,
    "costofrevenue": 3002000,
    "grossprofit": 3135000,
    "researchanddevelopmentexpense": 4065000,
    "generalandadministrativeexpense": 4669000,
    "operatingincomeloss": -5599000,
    "financialexpenses": 34000,
    "investmentincomenonoperating": 40000,
    "foreigncurrencytransactionlossbeforetaxes": 181000,
    "investmentincomeinvestmentexpense": 175000,
    "netincomeloss": -5774000,
    "comprehensiveincomenetoftax": -5774000,
    "earningspersharebasicanddiluted": 0.84,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 6886955,
    "sharesoutstanding": 6963838,
    "increasedecreaseinnumberofordinarysharesissuedvalue": 4400000,
    "stockissuedduringperiodsharesnewissues": 445000,
    "conversionofprepaidwarrantstoordinarysharesvalue": -355000,
    "conversionofprepaidwarrantstoordinaryshares": 811085,
    "stockissuedduringperiodvaluestockoptionsexercised": 89000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1250,
    "stockissuedduringperiodvalueissuedforservices": 69000,
    "stockissuedduringperiodsharesissuedforservices": 15429,
    "adjustmentstoadditionalpaidincapitaltaxeffectfromsharebasedcompensation": 1605000,
    "issuanceofordinarysharesandwarrants": 50000,
    "netcashusedinoperationsseeappendixa": 4451000,
    "netcashprovidedbyusedinoperatingactivities": -4451000,
    "paymentstoacquireintangibleassets": 82000,
    "paymentstoacquirepropertyplantandequipment": 437000,
    "netcashprovidedbyusedininvestingactivities": -519000,
    "proceedsfromissuanceofpreferredstockpreferencestockandwarrants": 4400000,
    "proceedsfromwarrantexercises": 89000,
    "repaymentsofdebt": 24000,
    "netcashprovidedbyusedinfinancingactivities": 4465000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -505000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 3526000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 60000,
    "depreciationandamortization": 408000,
    "allocatedsharebasedcompensationexpense": 1674000,
    "effectofexchangeratechangesoncashandcashequivalent": 60000,
    "financialexpensesrelatedtofinancialinstruments": -40000,
    "operatingleaseexpense": 213000,
    "adjustmentsnoncashitemstoreconcilenetincomelosstocashprovidedbyusedinoperatingactivities": -3327000,
    "increasedecreaseinaccountsreceivable": 751000,
    "increasedecreaseininventories": 374000,
    "increasedecreaseinotherreceivables": -31000,
    "increasedecreaseinaccountspayabletrade": -35000,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": 740000,
    "increasedecreaseindeferredrevenue": -735000,
    "increasedecreaseinoperatingcapital": 1124000,
    "adjustmentfornetcashprovidedbyusedinoperations": -4451000,
    "conversionofstockamountconverted1": 355000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 23000,
    "restricteddepositsincludinglongterm": 193000,
    "propertyplantandequipmentusefullife": "P10Y",
    "fairvaluemeasurementsprobability": 0.03,
    "expectedvolatility": 0.7078,
    "fairvaluemeasurementsriskfreeinterestrate": 0.0012,
    "fairvaluemeasurementsexpectedtermyears": "P1Y248D",
    "fairvalueoffinancialinstruments": -28000,
    "profitfromchangesinfairvalueofdebentures": 40000,
    "propertyplantandequipmentgross": 5585000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3479000,
    "inventoryworkinprocess": 391000,
    "inventoryfinishedgoods": 871000,
    "inventorygross": 1262000,
    "operatingleasepayments": 657000,
    "operatingleaseliability": 3388000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.073,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 649000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 622000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 568000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 484000,
    "lesseeoperatingleaseliabilitypaymentsdueafterrollingyearfive": 2038000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4361000,
    "lesseeoperatingleaseliabilityimputedinterest": 973000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 512622,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 11.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvaluesassumptionsexerciseprice": 10.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6641,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0052,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y40D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1198777,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.02,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.33,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 4332,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 61.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 14961,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 8057,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.42,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 18082,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 1216859,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P4Y25D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 357217,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P4Y7D",
    "effectofsharebasedcompensation": 1605000,
    "deferredtaxassetsoperatinglosscarryforwards": 13170000,
    "deferredtaxassetsinprocessresearchanddevelopment": 820000,
    "valuationoffinancialinstruments": 10000,
    "deferredtaxassetsvaluationallowance": 13980000,
    "valuationallowancedeferredtaxassetchangeinamount": 572000,
    "accountsreceivableandprepaidexpense": 239000,
    "tradepayablecurrent": 798000,
    "accountspayableandotheraccruedliabilities": 1943000,
    "revenuesfromlicensingagreement": 3600000,
    "revenuesfromsalesofgoods": 2108000,
    "revenuesfromrenderingofservices": 429000,
    "contractwithcustomerliability": 207000,
    "contractwithcustomerliabilityincreasedecreaseforcontractacquiredinbusinesscombination": -270000,
    "contractwithcustomerliabilityrevenuesrecognized": 1005000,
    "contractwithcustomerliabilitycurrent": 207000,
    "payrollandrelatedexpenses": 1973000,
    "sharebasedcompensationexpense": 464000,
    "subcontractorsandconsultants": 125000,
    "consumablesandmaterials": 262000,
    "paymentsforrent": 824000,
    "otherresearchanddevelopmentexpense": 9000,
    "researchanddevelopmentinprocess": 4065000,
    "costsandexpensesrelatedparty": 1495000,
    "sharebasedcompensation": 1075000,
    "directorssalaryandinsurance": 573000,
    "rentandofficemaintenance": 205000,
    "professionalandcontractservicesexpense": 1045000,
    "depreciation": 48000,
    "othergeneralandadministrativeexpense": 228000,
    "bankandotherfees": 11000,
    "otherexpenses": 23000,
    "operatingexpenses": 34000,
    "remeasurementoffinancialinstrumentsoffinancialincome": 40000,
    "totalfinancialincome": 40000,
    "foreigncurrencytransactionlossbeforetax": 181000,
    "transactionprice": 5000000,
    "reimbursementcost": 1000000,
    "effectiveincometaxratecontinuingoperations": 0.5,
    "warrantsexercisable": 4008007000,
    "financialliability": 28000,
    "disposedoffixedassets": 30000,
    "inventorywritedown": 55000,
    "restrictedcashandinvestments": 181000,
    "leaseandrentalexpense": 633000,
    "artistadvancesandroyaltyguaranteescommitments": "Under the Innovation Law the rate of royalties varies between 3% to 5% computed based on the revenues from the products that their development was also funded by grants from the IIA. In addition, revenues from certain milestone under the LB license, development and commercialization agreement were subject to royalties rate of 24.8%. Such commitment is up to the amount of grants received (dollar linked), plus interest at annual rate based on LIBOR.",
    "royaltyexpense": 795000,
    "royaltyguaranteescommitmentsamount": 8500000,
    "upfrontcashpayment": 5000000,
    "broadcasterslicenseagreementcommitmentsdescription": "In addition, the License Agreement provides for a one-time non-refundable option payments of $3,000 per Option Product ($9,000 in the aggregate), and up to $30,000 of milestone payments payable as follows: (i) $5,000 upon completion of the U.S. facility design, (ii) $5,000 upon completion of production of a specified amount of BioInk, and (iii) $5,000 for FDA marketing approval for each Covered Product (up to $20,000 in the aggregate).",
    "stockholdersequityreversestocksplit": "Unless otherwise indicated, all of the share and ADS numbers, losses per share, share prices, options and warrants in these financial statements have been adjusted, on a retroactive basis, to reflect this 1-for-50 reverse share split.",
    "optionexpirydescription": "10 years",
    "fairvalueoptionsgranted": 16000,
    "employeebenefitsandsharebasedcompensation": 1853000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 2882000,
    "stockissuedduringperiodvaluestockoptionsexercisednetoftaxbenefitexpense": 114000,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.23,
    "operatinglosscarryforwards": 51096,
    "concentrationriskpercentage1": 0.1,
    "entityregistrantname": "CollPlant Biotechnologies Ltd",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 6963838,
    "amendmentflag": "false",
    "entitycentralindexkey": 1631487,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documentshellcompanyreport": "false",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "L3",
    "entityinteractivedatacurrent": "Yes"
  },
  {
    "date": "2019-12-31",
    "symbol": "CLGN",
    "period": "FY",
    "entityregistrantname": "CollPlant Biotechnologies Ltd",
    "entitycentralindexkey": 1631487,
    "amendmentflag": "false",
    "documenttype": "20-F",
    "documentperiodenddate": "2019-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entityemerginggrowthcompany": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 5670829,
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "L3",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityextransitionperiod": "false",
    "cashandcashequivalents": 3791000,
    "tradereceivables": 79000,
    "othercurrentreceivables": 270000,
    "currentassetsrestricteddeposit": 12000,
    "inventories": 888000,
    "currentassets": 5040000,
    "noncurrentassetsrestricteddeposit": 168000,
    "rightofuseassets": 3215000,
    "propertyplantandequipment": 2329000,
    "noncurrentassets": 5712000,
    "assets": 10752000,
    "longtermloancurrent": 24000,
    "tradeandothercurrentpayablestotradesuppliers": 833000,
    "othercurrentpayables": 1203000,
    "currentleaseliabilities": 455000,
    "deferredincomeclassifiedascurrent": 942000,
    "currentliabilities": 3457000,
    "noncurrentdebtinstrumentsissued": 68000,
    "noncurrentleaseliabilities": 3139000,
    "noncurrentliabilities": 3207000,
    "liabilities": 6664000,
    "ordinaryshares": 2368000,
    "additionalpaidincapital": 69949000,
    "reserveofexchangedifferencesontranslation": -969000,
    "retainedearnings": -67260000,
    "equity": -969000,
    "equityandliabilities": 10752000,
    "parvaluepershare": 1.5,
    "numberofordinarysharessharesauthorized": 30000000,
    "numberofordinarysharessharesissued": 5670829,
    "numberofordinarysharessharesoutstanding": 5670829,
    "revenue": 2318000,
    "costofsales": 1879000,
    "grossprofit": 439000,
    "researchanddevelopmentexpense": 28000,
    "sellinggeneralandadministrativeexpense": 3656000,
    "profitlossfromoperatingactivities": -7631000,
    "financecosts": 3303000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -230000,
    "financeincomecost": -3533000,
    "profitloss": -11164000,
    "comprehensiveincome": -11164000,
    "basicanddilutedearningslosspershare": 2.23,
    "weightedaverageshares": 4986381,
    "numberofsharesoutstanding": 5671,
    "increasedecreaseinnumberofordinarysharesissuedvalue": 763000,
    "increasedecreaseinnumberofordinarysharesissued": 1800,
    "increasedecreasethroughclassificationofwarrantsfromequitytoliability": -1804000,
    "classificationofwarrantsfromliabilitytoequity": 3139000,
    "conversionofprepaidwarrantstoordinaryshares": 22000,
    "conversionofprepaidwarrantstoordinarysharesshares": 50,
    "increasedecreasethroughexerciseofoptions": 3000,
    "increasedecreasethroughexerciseofoptionsshares": 6,
    "increasedecreasethroughsharebasedpaymenttransactions": 1125000,
    "cashflowsfromusedinoperations": -5703000,
    "cashflowsfromusedinoperatingactivities": -5703000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 1491000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 30000,
    "cashflowsfromusedininvestingactivities": -1461000,
    "proceedsfromissuingshares": 5440000,
    "proceedsfromexerciseofoptions": 7000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 20000,
    "repaymentsofnoncurrentborrowings": 17000,
    "cashflowsfromusedinfinancingactivities": 5410000,
    "increasedecreaseincashandcashequivalents": -1754000,
    "restrictedcashandcashequivalents": 3971000,
    "effectofexchangeratechangesoncashandcashequivalents": 62000,
    "adjustmentsfordepreciationandamortisationexpense": 539000,
    "adjustmentsforsharebasedpayments": 1125000,
    "effectofexchangeratechangesoncashandcashequivalent": -62000,
    "changesinfairvalueandamortizationoffinancialinstruments": 3230000,
    "netchangeofoperatingleaseaccounts": 382000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -5950000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": 437000,
    "adjustmentsfordecreaseincreaseininventories": -74000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 35000,
    "adjustmentforincreaseinlongtermpayables": 228000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 629000,
    "increasedecreaseindeferredtaxliabilityasset": 1008000,
    "adjustmentsforreconcileprofitloss": 247000,
    "netcashusedinoperationsadditional": -5703000,
    "issueofconvertibleinstruments": 1804000,
    "conversionofprepaidwarrantstoordinaryshares1": 22000,
    "obtainingrightofuseassetsinexchangeforleaseliability": 97000,
    "exerciseofantidilutionderivatives": 2024000,
    "classificationofwarrantsfromliabilitiestoequity": 1335000,
    "ordinarysharedescription": "The Company's ADSs, such that its ratio of ADSs to ordinary shares changed from one (1) ADS representing fifty (50) ordinary shares to a new ratio of one (1) ADS representing one (1) ordinary share. The first date when the Company's ADSs began trading on the Nasdaq Capital Market after implementation of the reverse split and concurrent ratio change was July 15, 2019.",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P10Y",
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 3458000,
    "warrantsexercisable": 3536495,
    "transactionprice": 5000000,
    "reimbursementrightsatfairvalue": 1000000,
    "fairvaluemeasurementsprobabilityexplanatory": 0.03,
    "expectedvolatilityexplanatory": 0.5958,
    "fairvalueriskfreeinterestrateexplanatory": 0.0162,
    "fairvalueexpectedtermyearsexplanatory": "P2Y8M5D",
    "fairvalueoffinancialinstruments": -68000,
    "issuancewarrants": -100000,
    "profitfromchangesinfairvalueofdebentures": -1335000,
    "classificationofwarrantsfromliabilitytoequity1": 3139000,
    "derivativesliabilitiesnoncurrent": 68000,
    "computersoftware": 267000,
    "fixturesandfittings": 181000,
    "officeequipment": 1631000,
    "greenhouseequipment": 713000,
    "leaseholdimprovements": 2271000,
    "motorvehicles": 84000,
    "owneroccupiedpropertymeasuredusinginvestmentpropertyfairvaluemodel": 5147000,
    "propertyplantandequipmentgrosscarryingamountfullydepreciated": 2818000,
    "workinprogress": 422000,
    "finishedgoods": 466000,
    "inventorywritedown2011": 44000,
    "cashflowsfromusedinincreasesinoperatingcapacity": 505000,
    "leaseliabilities": 3594000,
    "operatingleasestermexplanatory": "P8Y4M24D",
    "operatingleasespercentage": 0.073,
    "maturitiestotalleasepayments": 2294000,
    "operatinglessimputedinterests": -1081000,
    "operatingleasepaymentsnet": 3594000,
    "cashoutflowforleases": 619000,
    "rentalexpense": 296000,
    "variableleasepayments": 9000,
    "descriptionofmaterialleasingarrangementsbylesseeclassifiedasoperatinglease": "Under the Innovation Law the rate of royalties varies between 3% to 5% computed based on the revenues from the products that their development was also funded by grants from the IIA. Such commitment is up to the amount of grants received (dollar linked), plus interest at annual rate based on LIBOR.",
    "grantstotalamount": 38000,
    "royaltyexpense": 43000,
    "valueaddedtaxpayables": 145000,
    "maximumtotalroyaltyamount": 8600000,
    "numberofoptionsawardamount": 301390,
    "optionsgrantexerciseprice": 5.07,
    "optionsgrantsvestingperiod": "P4Y",
    "optiongrantsexpiration": "P7Y",
    "exercisepriceshareoptionsgranted": 5.93,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.49,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.02,
    "descriptionofoptionslifeshareoptionsgranted": "P5Y6M0D",
    "numberofoutstandingshareoption": 23664,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 5000,
    "numberofshareoptionexercisedinsharebasedpaymentarrangement": 6076,
    "numberofshareoptionexpiredinsharebasedpaymentarrangement": 11891,
    "numberofshareoptionforfeitedinsharebasedpaymentarrangement": 304677,
    "numberofshareoptionexercisableinsharebasedpaymentarrangement": 10202,
    "weightedaverageexercisepriceofshareoptionsoutstanding": 4.38,
    "weightedaverageexercisepriceofshareoptionsgranted": 5.07,
    "weightedaverageexercisepriceofshareoptionsexpired": 1.3,
    "weightedaverageexercisepriceofshareoptionsexercised": 23.83,
    "weightedaverageexercisepriceofshareoptionsforfeited": 5.84,
    "weightedaverageexercisepriceofshareoptionsexercisable": 4.02,
    "weightedaverageremainingcontractuallifeoptionsoutstandingatbeginningofyear": "P0Y10M6D",
    "numberofoutstandingsharesoptions": 6998,
    "numberofoptionsexercisable": 6998,
    "weightedaverageremainingcontractuallifeoptionsexercisable": "P0Y10M6D",
    "adjustmentsforsharebasedpayment": 576000,
    "shareholdersreversesharesplitdescription": "1-for-50 reverse share split.",
    "explanationofshareoptionsinsharebasedpaymentarrangement": "The incremental fair value of the fully vested options as of October 27, 2019 in the amount of $341 was recognized immediately.",
    "sharebasedpaymentexerciseprice": 4.02,
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "The remaining incremental fair value will be recognized over the remaining vesting period and until March 2022.",
    "descriptionoftermshareoptionsgranted": "P0Y4M24D",
    "fairvalueoptionsgranted": 16000,
    "repricevalueofshares": 635000,
    "sharebasedpaymentnumberoptionsgranted": 171287,
    "keymanagementpersonnelcompensationsharebasedpaymentunrecognizedcompensation": 679000,
    "incrementalfairvalueofoptions": 478000,
    "intrinsicvalueoftotaloutstandingoption": 521000,
    "intrinsicvalueofoptionsexercisable": 25000,
    "netoperatinglosscarryforward": 12607000,
    "researchanddevelopmentexpenses": 801000,
    "valuationallowance": 13408000,
    "deferredincometaxesvaluationallowance": 13408000,
    "deferredincometaxesvaluationallowanceadditions": 2485000,
    "applicabletaxrate": 0.23,
    "incometaxlosscarryforwards": 50309000,
    "institutions": 124000,
    "prepaidexpenses": 84000,
    "other": 62000,
    "totalaccountreceivable": 270000,
    "tradepayableinusd": 35000,
    "tradepayableinnis": 798000,
    "totaltradepayablebycurrancy": 833000,
    "employeesandinstitutionsforemployees": 799000,
    "provisionsforvacationandothers": 245000,
    "otheraccountspayable": 159000,
    "totalaccountspayableandaccruals": 1203000,
    "revenuesfromsalesofgoods": 1949000,
    "revenuesfromrenderingofservices": 369000,
    "totalrevenues": 2318000,
    "revenuebyunitedstatesandcanada": 2078000,
    "revenuebyeurope": 240000,
    "totalrevenuesbygeographicalarea": 2318000,
    "revenuefromcustomera": 1374000,
    "revenuefromcustomerd": 419000,
    "revenuefromcustomere": 242000,
    "deferredrevenuebalanceatbeginning": -1950000,
    "revenuerecognizedduringperiod": 1008000,
    "deferredrevenuebalanceatend": -942000,
    "contractliabilitypresentedincurrentliabilities": -942000,
    "payrollandrelatedexpenses": 1954000,
    "sharebasedpayments": 549000,
    "subcontractorsandconsultants": 77000,
    "consumablesandmaterials": 304000,
    "depreciationandamortizationexpenses": 354000,
    "rentandmaintenance": 980000,
    "otherresearchanddevelopment": 224000,
    "researchanddevelopmentgross": 4442000,
    "iiaparticipationinrdexpenses": -28000,
    "totalparticipationexpense": -28000,
    "researchanddevelopmentnet": 4414000,
    "generalpayrollandrelatedexpenses": 1293000,
    "generalsharebasedpayments": 576000,
    "directorssalaryandinsurance": 415000,
    "rentandofficemaintenance": 84000,
    "professionalservices": 1012000,
    "generaldepreciation": 33000,
    "otherexpense": 243000,
    "generaladministrativeandmarketing": 3656000,
    "bankandotherfees": 63000,
    "remeasurementoffinancialinstruments": 3230000,
    "otherfinancingexpenses": 10000,
    "totalfinancingexpenses": 3303000
  }
]